Vijayashree Murthy

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer”.

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer

Cancers(2021)10.3390/cancers13164167

N/A

0.385DataRank · unranked

12 citations

Jessica Young, Yoshihisa Tokumaru, Marie Quinn, Stephen B. Edge, Kazuaki Takabe +1 more

Urine as a Source of Liquid Biopsy for Cancer

Cancers(2021)10.3390/cancers13112652

N/A

0DataRank · unranked

128 citations

Vijayashree Murthy, Hideo Takahashi, Michelle R. Huyser, Maiko Okano, Yoshihisa Tokumaru +5 more

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment

Cancers(2021)10.3390/cancers13112559

N/A

0DataRank · unranked

37 citations

Masanori Oshi, Vijayashree Murthy, Elizabeth A. Repasky, Kazuaki Takabe, Shipra Gandhi

ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer

Cancers(2020)10.3390/cancers12102758

N/A

0DataRank · unranked

46 citations

Stephanie Newman, Vijayashree Murthy, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama +3 more

Low expression of microRNA-195 is a poor prognostic marker for ER-positive breast cancer patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12576

N/A

0DataRank · unranked

2 citations

Masanori Oshi, Eriko Katsuta, Vijayashree Murthy, Nobuhisa Matsuhashi, Manabu Futamura +3 more

Can Intratumoral neutrophil lymphocyte ratio (NLR) be a prognostic biomarker in breast cancer patients?

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12573

N/A

0DataRank · unranked

2 citations

Masanori Oshi, Vijayashree Murthy, Eriko Katsuta, Nobuhisa Matsuhashi, Manabu Futamura +3 more

miR-150 expression in breast cancer attracts and activates immune cells, and is associated with better patient outcome.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.570

N/A

0DataRank · unranked

3 citations

Aparna Maiti, Rongrong Wu, Yoshihisa Tokumaru, Vijayashree Murthy, Li Yan +5 more